Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Kidney International|November 21, 2025
Untangling causality in nephrology: the example of CKD-MBD and disease progressionSolène M Laville, Sophie LiabeufNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2018
From old uraemic toxins to new uraemic toxins: place of 'omics'Ziad A Massy, Sophie LiabeufContributions to Nephrology|September 15, 2017
Middle-Molecule Uremic Toxins and Outcomes in Chronic Kidney DiseaseZiad A Massy, Sophie LiabeufKidney International|February 22, 2022
Sortilin, carbamylation, and cardiovascular calcification in chronic kidney diseaseZiad A Massy, Sophie LiabeufToxins|June 8, 2018
Uremic Toxins and Clinical Outcomes: The Impact of Kidney TransplantationSophie Liabeuf, Lynda Cheddani, Ziad A MassyToxins|April 21, 2022
Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?Carolla El Chamieh, Sophie Liabeuf, Ziad MassyClinical Science (London, England : 1979)|November 2, 2016
Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?Sophie Liabeuf, Cédric Villain, Ziad A MassyToxins|November 10, 2011
Protein-bound uremic toxins: new insight from clinical studiesSophie Liabeuf, Tilman B Drüeke, Ziad A MassyClinical Kidney Journal|February 5, 2025
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populationsSophie Liabeuf, Roberto Minutolo, Jürgen Floege, et al.Therapie|March 25, 2020
Self-medication practices and their characteristics among French university studentsMarion Gras, Valérie Champel, Kamel Masmoudi, et al.Pageof 18